1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. British Columbia >
  6. Mydecine Innovations Group Acquires Mindleap Health

M&A Deal Summary

Mydecine Innovations Group Acquires Mindleap Health

On May 21, 2020, Mydecine Innovations Group acquired healthcare services company Mindleap Health for 4M CAD

Acquisition Highlights
  • This is Mydecine Innovations Group’s 1st transaction in the Healthcare Services sector.
  • This is Mydecine Innovations Group’s largest (disclosed) transaction.
  • This is Mydecine Innovations Group’s 1st transaction in Canada.
  • This is Mydecine Innovations Group’s 1st transaction in British Columbia.
Investment Fate
  • Mindleap Health was divested to a consortium of strategic buyers in 2022 for 4M CAD.

M&A Deal Summary
Date 2020-05-21
Target Mindleap Health
Sector Healthcare Services
Buyer(s) Mydecine Innovations Group
Deal Type Add-on Acquisition
Deal Value 4M CAD

Target

Mindleap Health

Vancouver, British Columbia, Canada
Mindleap Health is an advanced digital health platform that helps people connect with mental health specialists that can empower them to thrive and develop habits for a healthy mind. The company's online mental healthcare brings convenience, improves access to treatments, and can lead to more personal breakthroughs. Its proprietary platform is designed by clinical psychologists and neuroscientists to provide professional support and personalized treatment for every person. Mindleap Health was formed in 2019 and is based in Vancouver, British Columbia.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Mydecine Innovations Group

Toronto, Ontario, Canada
Category Company
Founded 2013
Sector Consumer Products
DESCRIPTION

Mydecine Innovations Group is a cannabidiol lifestyle company focused on the development, marketing, and distribution of CBD products (including vaporizer pens/cartridges, hot/cold tea, soft gel capsules, and beverages) throughout North America, South America, and Europe. Mydecine Innovations Group was founded in 2013 and is based in Toronto, Ontario.

DEAL STATS #
Overall 4 of 5
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 3
State: British Columbia M&A 1 of 2
Country: Canada M&A 1 of 2
Year: 2020 M&A 4 of 5
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-04-23 Levee Street Holdings

Dallas, Texas, United States

Levee Street Holdings LLC is a distributor of CBD products including We Are Kured, LLC, ReLyfe Brands, LLC, TeaLief Brands, LLC and Drink Fresh Water, LLC based in Dallas, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-10 NeuroPharm

Vancouver, British Columbia, Canada

NeuroPharm, Inc. is a healthcare company that develops pharmaceutical and natural health products addressing mental wellness in vulnerable populations such as Veterans and Emergency Medical Services (EMS) personnel. NeuroPharm is based in Vancouver, British Columbia.

Buy $6M
Mergr

Solution for

Product

Company

Legal